Clinical Trial Update: Study of Acamprosate to Prevent Alcohol Relapse in Criminal Justice Supervisees [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating acamprosate to prevent alcohol relapse in criminal justice supervisees was terminated; results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Dependence

Drugs mentioned

• acamprosate (acamprosate)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Alcohol Dependence | Phase 4 | Status: TERMINATED | Results posted: 2016-05-11